Pentoxifylline as a Potential Adjuvant Therapy for COVID-19: Impeding the Burden of the Cytokine Storm

Pentoxifylline as a Potential Adjuvant Therapy for COVID-19: Impeding the Burden of the Cytokine Storm

The outburst of inflammatory response and hypercoagulability are among the factors contributing to increased mortality in severe COVID-19 cases. Pentoxifylline (PTX), a xanthine-derived drug registered for the treatment of vascular claudication, has been reported to display broad-spectrum anti-infla...

Full description

Saved in:
Bibliographic Details
Main Authors: Wiktoria Feret, Magdalena Nalewajska, Łukasz Wojczyński, Wojciech Witkiewicz, Patrycja Kłos, Violetta Dziedziejko, Andrzej Pawlik
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
COVID-19
SARS-CoV-2
cytokine storm
cytokines
pentoxifylline
pneumonia
Medicine
R
Online Access:https://doaj.org/article/cf4240f217e4421e845f64298641d07c
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/cf4240f217e4421e845f64298641d07c

Similar Items